Loading…
Envoy Medical, Inc. is projected to rise to $0.9175 by 2027, a +33% move from its current price of $0.6905. COCH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6658 | $0.6903 | $0.7158 | -0.02% |
| Aug 6 | $0.6557 | $0.6902 | $0.7265 | -0.04% |
| Aug 7 | $0.6481 | $0.69 | $0.7347 | -0.07% |
| Aug 8 | $0.6417 | $0.6899 | $0.7417 | -0.09% |
| Aug 9 | $0.6361 | $0.6897 | $0.7479 | -0.11% |
| Aug 10 | $0.631 | $0.6896 | $0.7536 | -0.13% |
| Aug 11 | $0.6264 | $0.6894 | $0.7588 | -0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6264 | $0.6894 | $0.7588 | -0.15% |
| Week 2 | $0.6011 | $0.6884 | $0.7883 | -0.31% |
| Week 3 | $0.5822 | $0.6873 | $0.8114 | -0.46% |
| Week 4 | $0.5665 | $0.6862 | $0.8312 | -0.62% |
| Week 5 | $0.553 | $0.6852 | $0.8489 | -0.77% |
| Week 6 | $0.541 | $0.6841 | $0.8651 | -0.93% |
| Week 7 | $0.5301 | $0.683 | $0.8802 | -1.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Envoy Medical, Inc. is a Healthcare company focused on hearing health. It provides medical technologies across the hearing loss spectrum and offers personal sound amplification devices, hearing aids, Esteem fully implanted active middle ear implants, auditory osseointegrated implants, and Acclaim cochlear implants.
The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Envoy Medical, Inc. (COCH) is a Healthcare stock with a current price of $0.6433 and a market cap of $49.55M. It ranks 4541. The near-term price picture and risk lie in the 30-day technical setup, with a range that reflects ongoing volatility. The forecast suggests a neutral stance in 2026, followed by bullish momentum in later years.
A major floor 22.6% below — a decisive break under it would weaken the trend.
The nearest floor, 8.6% below — buyers have tended to step in here.
The nearest ceiling, 15.3% above — a clean break opens room to run.
A major ceiling 25.2% above — clearing it would confirm fresh momentum.
Key COCH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COCH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6668 | Buy | $0.6678 | Buy |
| MA 10 | $0.6703 | Buy | $0.6752 | Buy |
| MA 20 | $0.6986 | Sell | $0.6852 | Buy |
| MA 50 | $0.69 | Buy | $0.6894 | Buy |
| MA 100 | $0.6955 | Sell | $0.7019 | Sell |
| MA 200 | $0.7074 | Sell | $0.813 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.26 | Neutral |
| Stoch RSI (14) | 30.46 | Neutral |
| CCI (20) | -57.37 | Neutral |
| Williams %R (14) | -76.07 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -7.32 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 23.93 | Neutral |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 43.68 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.66 | Buy |
| ADX (14) | 9.25 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is BEARISH, with RSI(14) at 40. The stock trades near the SMA50 of $0.6923 and the SMA200 of $0.7096, with a defined support at $0.631 and resistance at $0.796. The 30-day range spans from $0.5021 to $0.8241, illustrating ongoing short-term variability.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.39 | $0.6905 | $0.8318 | 0% | Neutral | |
| $0.7102 | $0.9175 | $1.27 | +33% | Bullish | |
| $0.7312 | $0.982 | $1.42 | +42% | Bullish | |
| $0.6944 | $0.9634 | $1.45 | +40% | Bullish | |
| $0.7278 | $1.04 | $1.61 | +50% | Bullish | |
| $0.6567 | $0.9627 | $1.53 | +39% | Bullish | |
| $0.6773 | $1.02 | $1.66 | +47% | Bullish | |
| $0.7643 | $1.18 | $1.95 | +70% | Bullish | |
| $0.8319 | $1.31 | $2.22 | +90% | Bullish | |
| $0.9608 | $1.54 | $2.67 | +124% | Bullish | |
| $1.04 | $1.85 | $3.44 | +168% | Bullish | |
| $1.48 | $3.15 | $6.53 | +356% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.39 | $0.6905 | $0.8037 | +0.00% |
| September 2026 | $0.5651 | $0.6744 | $0.8318 | -2.33% |
| October 2026 | $0.5618 | $0.6767 | $0.8465 | +0.34% |
| November 2026 | $0.5322 | $0.6459 | $0.8172 | -4.55% |
| December 2026 | $0.5325 | $0.6508 | $0.8318 | +0.76% |
Click any year to see its month-by-month COCH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, COCH is projected to trade between $0.39 and $0.8318, averaging $0.6905 — a potential gain of 0% from today's $0.6905. Price action looks broadly range-bound.
Envoy Medical, Inc.'s 2027 outlook centres on $0.9175, within a $0.7102 to $1.27 range. That is up +33% on the projected 2026 average. That marks a +33% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, COCH could reach as high as $1.42, with a base case around $0.982 and support toward $0.7312 — roughly +42% from $0.6905. Momentum favours further upside here.
Expect COCH to range from $0.6944 to $1.45 through 2029. The $0.9634 average target implies a +40% move from current prices. That is -2% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The COCH price prediction for 2030 points to an average of $1.04 (low $0.7278, high $1.61) — a potential gain of +50% on today's $0.6905. Momentum favours further upside here.
In 2031, COCH is projected to trade between $0.6567 and $1.53, averaging $0.9627 — a potential gain of +39% from today's $0.6905. That is -7% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Envoy Medical, Inc.'s 2032 outlook centres on $1.02, within a $0.6773 to $1.66 range. That is up +6% on the projected 2031 average. That marks a +47% change versus current levels. Momentum favours further upside here.
By 2033, COCH could reach as high as $1.95, with a base case around $1.18 and support toward $0.7643 — roughly +70% from $0.6905. Buyers look set to stay in control over this stretch.
Expect COCH to range from $0.8319 to $2.22 through 2034. The $1.31 average target implies a +90% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The COCH price prediction for 2035 points to an average of $1.54 (low $0.9608, high $2.67) — a potential gain of +124% on today's $0.6905. Buyers look set to stay in control over this stretch.
In 2040, COCH is projected to trade between $1.04 and $3.44, averaging $1.85 — a potential gain of +168% from today's $0.6905. That is up +20% on the projected 2035 average. Momentum favours further upside here.
Envoy Medical, Inc.'s 2050 outlook centres on $3.15, within a $1.48 to $6.53 range. That is up +70% on the projected 2040 average. That marks a +356% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in COCH today (≈ 1,448.225923 COCH) could be worth
$4,564.95
+$3,564.95 (+356%) by 2050 · US Dollar
Based on the average projected COCH price of $3.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in COCHwould be worth at today's price.
$1,000 invested in COCH on Jul 31, 2025 (≈ 684.931489 COCH) would be worth
$472.95
-$527.05 (-52.7%) today · 0.47× · US Dollar
Based on a COCH entry price of $1.46 vs. today's $0.6905.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.663 | $1,041.48 | +4.1% |
| 1 month ago | $0.79 | $874.05 | -12.6% |
| 3 months ago | $0.681 | $1,013.95 | +1.4% |
| 6 months ago | $0.65 | $1,062.31 | +6.2% |
| 1 year ago | $1.46 | $472.95 | -52.7% |
| All time (5.0y) ago | $9.65 | $71.55 | -92.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COCH forecast.
Our base-case forecast reaches $1.40 around 2035.
Implied market cap at $1.40: $107.83M
The multi-year outlook shows a neutral start in 2026, with an average price of $0.6433 and a max of $0.7721, and a 0% ROI. From 2027 onward, the forecast turns bullish, with the 2027 average at $0.8367 and ROI of 30.1%, rising through 2028 at $0.8902 (38.4%), 2029 at $0.8739 (35.9%), and 2030 at $0.9345 (45.3%). The bullish path continues with 2031 at $0.8486 (31.9%), 2032 at $0.8908 (38.5%), 2033 at $1.01 (56.3%), 2034 at $1.11 (72.8%), and 2035 at $1.34 (108.8%).
By 2040, the forecast shows $1.51 (135.4%), and by 2050 an average of $2.64 with a max of $5.56 and ROI of 310.2%. Overall, the outlook remains bullish across these years, though these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 avg $0.9345, min $0.6483, max $1.46; ROI 45.3%; sentiment BULLISH.
Yes. The forecast shows a neutral stance in 2026 (avg $0.6433, max $0.7721, min $0.39, ROI 0) and bullish sentiment thereafter, with increasing averages and ROIs through 2050 (e.g., 2027 avg $0.8367, ROI 30.1%; 2050 avg $2.64, ROI 310.2%).
2040 min $0.8357, avg $1.51, max $2.86, ROI 135.4%, sentiment BULLISH.
Current price $0.6433; market cap $49.55M.
Envoy Medical, Inc. Community Discussion
0Share your Envoy Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.